Log in

goodpods headphones icon

To access all our features

Open the Goodpods app
Close icon
headphones
The Bob Harrington Show

The Bob Harrington Show

Medscape

The Bob Harrington Show is a podcast series of thoughtful interviews and discussions on topics at the core of cardiology and the practice of medicine.
bookmark
Share icon

All episodes

Best episodes

Top 10 The Bob Harrington Show Episodes

Goodpods has curated a list of the 10 best The Bob Harrington Show episodes, ranked by the number of listens and likes each episode have garnered from our listeners. If you are listening to The Bob Harrington Show for the first time, there's no better place to start than with one of these standout episodes. If you are a fan of the show, vote for your favorite The Bob Harrington Show episode by adding your comments to the episode page.

The Bob Harrington Show - Top Cardiology Trials of 2021

Top Cardiology Trials of 2021

The Bob Harrington Show

play

12/16/21 • 27 min

Drs Harrington and Gibson provide their annual roundup of what they consider the key cardiovascular trials of 2021. This podcast is intended for healthcare professionals only. To read a transcript or to comment, visit

This podcast is intended for US healthcare professionals only.

To read a full transcript of this episode or to comment please visit:

https://www.medscape.com/viewarticle/963475

https://www.medscape.com/author/bob-harrington

Antiplatelet Therapy

Comparative Effectiveness of Aspirin Dosing in Cardiovascular Disease

https://doi.org/10.1056/NEJMoa2102137

Dual Antiplatelet Therapy after PCI in Patients at High Bleeding Risk

https://doi.org/10.1056/NEJMoa2108749

Effect of 1-Month Dual Antiplatelet Therapy Followed by Clopidogrel vs 12-Month Dual Antiplatelet Therapy on Cardiovascular and Bleeding Events in Patients Receiving PCI

https://doi.org/10.1001/jama.2019.8145

Aspirin Versus Clopidogrel for Chronic Maintenance Monotherapy After Percutaneous Coronary Intervention (HOST-EXAM): An Investigator-Initiated, Prospective, Randomised, Open-Label, Multicentre Trial

https://doi.org/10.1016/S0140-6736(21)01063-1

SGLT2 Inhibitors and GLP-1 Agonists

Empagliflozin in Heart Failure with a Preserved Ejection Fraction

https://www.nejm.org/doi/full/10.1056/NEJMoa2107038

Once-Weekly Semaglutide in Adults with Overweight or Obesity

https://www.nejm.org/doi/full/10.1056/NEJMoa2032183

Cardiac Surgery and PCI

Left Atrial Appendage Occlusion during Cardiac Surgery to Prevent Stroke

https://doi.org/10.1056/NEJMoa2101897

Concomitant Tricuspid Repair in Patients with Degenerative Mitral Regurgitation

https://doi.org/10.1056/NEJMoa2115961

Fractional Flow Reserve–Guided PCI as Compared with Coronary Bypass Surgery

https://doi.org/10.1056/NEJMoa2112299

You may also like:

Medscape editor-in-chief Eric Topol, MD, and master storyteller and clinician Abraham Verghese, MD, on Medicine and the Machine

https://www.medscape.com/features/public/machine

Hear John Mandrola, MD's summary and perspective on the top cardiology news each week, on This Week in Cardiology

https://www.medscape.com/twic

Questions or feedback? Please contact [email protected]

bookmark
plus icon
share episode
The Bob Harrington Show - Incentivizing Cardiologists to Do the Right Thing
play

04/23/18 • 20 min

Drs Harrington and Joynt Maddox discuss the move from volume-based to performance-based payment models and how to develop evidence-based quality metrics that make clinical sense.
bookmark
plus icon
share episode
The Bob Harrington Show - Dr Rob Califf on His Short-Lived Tenure as FDA Commissioner
play

07/06/17 • 13 min

From being critiqued by Bernie Sanders to the controversial Duchenne drug approval decision, Dr Califf recounts his experiences as FDA commissioner.
bookmark
plus icon
share episode
The Bob Harrington Show - Cardiology 2015: The Year in Review
play

12/21/15 • 26 min

Drs Harrington and Gibson give their annual review of the highs and lows in medicine with a focus on cardiology.
bookmark
plus icon
share episode
The Bob Harrington Show - Top Cardiology Trials of 2020 in Review
play

12/15/20 • 27 min

The annual tradition continues as did cardiology research despite a pandemic. Trials on fish oils, statins, SGLT2 inhibitors, and antiplatelets are among the selections of Drs Harrington and Gibson.

bookmark
plus icon
share episode
The Bob Harrington Show - Pandemic Publishing: Speed vs Quality Control
play

08/27/20 • 30 min

Three editors of cardiology journals -- Drs Harrington, Yancy, and Nallamothu -- discuss the challenges of maintaining quality during the COVID-19 surge in submissions.

bookmark
plus icon
share episode
The Bob Harrington Show - Thrombosis in COVID-19: What We Know and How to Treat
play

06/18/20 • 25 min

Hematologist Mary Cushman discusses arterial and venous thrombosis issues with SARS-CoV-2 and the role of anticoagulation.

bookmark
plus icon
share episode
The Bob Harrington Show - Cardiology 2019: Top Trials in Review
play

12/17/19 • 34 min

'It's like we're in the '90s again.' Drs Gibson and Harrington review top cardiology trials on revascularization, lipid management, and antithrombotics in part 1 of their annual wrap-up.

bookmark
plus icon
share episode
Drs Harrington and Gibson discuss burning issues in medicine, including artificial intelligence, social media, wearable tech, and the new hypertension guidelines.
bookmark
plus icon
share episode
The Bob Harrington Show - The Top Cardiology Trials of 2023

The Top Cardiology Trials of 2023

The Bob Harrington Show

play

12/15/23 • 35 min

For this year's review, Bob Harrington and Mike Gibson revisit the major cardiology conferences -- from ACC in New Orleans to AHA in Philly.

This podcast is intended for healthcare professionals only.

To read a transcript or to comment, visit:

https://www.medscape.com/author/bob-harrington

ACC 2023 Top Trials

Bempedoic Acid Cuts CV Events in Statin-Intolerant Patients: CLEAR Outcomes https://www.medscape.com/viewarticle/989100

Bempedoic Acid and Cardiovascular Outcomes in Statin-Intolerant Patients

Phase 2b Randomized Trial of the Oral PCSK9 Inhibitor MK-0616 https://www.jacc.org/doi/10.1016/j.jacc.2023.02.018

ACC/WCC 2023 Collection Page https://www.medscape.com/viewcollection/36966

ESC 2023 Top Trials

Wegovy Scores HFpEF Benefits in People With Obesity https://www.medscape.com/viewarticle/995844

Semaglutide in Patients with Heart Failure with Preserved Ejection Fraction and Obesity https://www.nejm.org/doi/full/10.1056/NEJMoa2306963

Acoramidis Shows Encouraging Results in ATTR Cardiomyopathy https://www.medscape.com/viewarticle/995883

ESC 2023 Collection Page https://www.medscape.com/viewcollection/36988

AHA 2023 Top Trials

Semaglutide 'A New Pathway' to CVD Risk Reduction: SELECT https://www.medscape.com/viewarticle/998373

Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes https://www.nejm.org/doi/full/10.1056/NEJMoa2307563

Bariatric Surgery is Associated With Improved Coronary Microvascular Function and Cardiorespiratory Fitness in Patients With Ischemia and Non-Obstructive Coronary Arteries https://www.ahajournals.org/doi/10.1161/circ.148.suppl_1.18949

Angioplasty Finally Proven Beneficial in Stable Angina: ORBITA-2 https://www.medscape.com/s/viewarticle/998375

A Placebo-Controlled Trial of Percutaneous Coronary Intervention for Stable Angina https://www.nejm.org/doi/full/10.1056/NEJMoa2310610

Impressive Bleeding Profile With Factor XI Inhibitor in AF: AZALEA https://www.medscape.com/viewarticle/998418

Promising First Results With DNA Editing to Lower LDL https://www.medscape.com/s/viewarticle/998719

Single Injection Reduces Blood Pressure for 6 Months: KARDIA-1 https://www.medscape.com/viewarticle/998666

AHA 2023 Collection Page https://www.medscape.com/viewcollection/37277

Other Mentions

N-of-1 Trial of a Statin, Placebo, or No Treatment to Assess Side Effects https://www.nejm.org/doi/full/10.1056/NEJMc2031173

Rimonabant: From RIO to Ban https://doi.org/10.1155%2F2011%2F432607

Percutaneous coronary intervention in stable angina (ORBITA): a double-blind, randomised controlled trial https://doi.org/10.1016/S0140-6736(17)32714-9

Asundexian Phase 3 AF Study Halted for Lack of Efficacy https://www.medscape.com/viewarticle/998665

Challenges in the Design and Interpretation of Noninferiority Trials https://www.nejm.org/doi/full/10.1056/nejmra1510063

Milvexian for the Prevention of Venous Thromboembolism https://www.nejm.org/doi/full/10.1056/NEJMoa2113194

You may also like:

Medscape editor-in-chief Eric Topol, MD, and master storyteller and clinician Abraham Verghese, MD, on Medicine and the Machine

https://www.medscape.com/features/public/machine

Hear John Mandrola, MD's summary and perspective on the top cardiology news each week, on This Week in Cardiology

https://www.medscape.com/twic

Questions or feedback, please contact [email protected]

bookmark
plus icon
share episode

Show more best episodes

Toggle view more icon

FAQ

How many episodes does The Bob Harrington Show have?

The Bob Harrington Show currently has 65 episodes available.

What topics does The Bob Harrington Show cover?

The podcast is about Health & Fitness, Cardiology, Medicine, Podcasts, Science and Health.

What is the most popular episode on The Bob Harrington Show?

The episode title 'The Medical Student Teaching Medicine About Structural Racism' is the most popular.

What is the average episode length on The Bob Harrington Show?

The average episode length on The Bob Harrington Show is 22 minutes.

How often are episodes of The Bob Harrington Show released?

Episodes of The Bob Harrington Show are typically released every 51 days, 22 hours.

When was the first episode of The Bob Harrington Show?

The first episode of The Bob Harrington Show was released on Nov 26, 2013.

Show more FAQ

Toggle view more icon

Comments